Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,938,373 Methods of electrospinning and compositions made therefrom
Disclosed herein are methods of electrospinning poly(glycerol sebacate) (PGS) which allow stable PGS fibers and fibrous PGS constructs, scaffolds and grafts to...
US-9,938,372 Formulation methodology for distortional thermosets
Methods and formulations for distortional thermosets are disclosed that display enhanced composite mechanical performances and robust sorption resistance. The...
US-9,938,371 Composition for heat-dissipation member, heat-dissipation member, and electronic device
A composition capable of forming a heat-dissipation member having high thermal conductivity, and a heat-dissipation member. The composition for the...
US-9,938,370 Curable composition based on polymers containing silane groups and on a zinc catalyst
Composition including at least one polymer containing silane groups and at least one zinc(II) complex compound of Zn.sub.k(L).sub.x(Y).sub.2k-nx, where k is an...
US-9,938,369 Use of succinonitrile in the production of polyisocyanates comprising iminooxadiazinedione groups
The present invention relates to a method for producing polyisocyanates comprising iminooxadiazinedione groups, wherein at least one monomeric di- and/or...
US-9,938,368 Bio-inspired method to obtain multifunctional dynamic nanocomposites
A method for a polymeric or nanocomposite material. The method includes assembling a multiphase hard-soft structure, where the structure includes a hard micro-...
US-9,938,367 Polymer particles
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
US-9,938,366 Acrylic copolymer composition prepared from vinyl ester or amide functional monomers
The present invention is directed to an acrylic copolymer composition prepared from a monomer composition. The monomer composition is essentially free of...
US-9,938,365 Articles containing precisely branched functional polymeric phase change materials
A temperature regulating article comprises a substrate and a polymeric phase change material bound to the substrate, wherein the polymeric phase change material...
US-9,938,364 Substituted metallocene catalysts
This invention relates to novel bridged a hafnium transition metal metallocene catalyst compounds having two indenyl ligands substituted at the 4 position,...
US-9,938,363 Method for obtaining and isolating polychloroprene solids
The invention relates to methods for isolating and obtaining polychloroprene solids, wherein an aqueous polychloroprene dispersion is brought in contact with...
US-9,938,362 Isoprene polymerization catalyst composition, method for producing synthetic polyisoprene, and synthetic...
An isoprene polymerization catalyst composition includes: Component (a): a rare earth element compound having a rare earth element-oxygen bond or a rare earth...
US-9,938,361 Methods for preparing catalyst systems with increased productivity
Methods for producing catalyst systems with increased productivity are disclosed. The methods may comprise providing a catalyst composition comprising a solvent...
US-9,938,360 Catalyst comprising a metallocene complex and a co-catalyst
A process for the preparation of ethylene .alpha.-olefin copolymers by copolymerizing ethylene with .alpha.-olefins in the presence of a catalyst formed by...
US-9,938,359 Process for the preparation of ethylene polymers
A process for the preparation of ethylene polymers comprising polymerizing ethylene, optionally with one or more .alpha.-olefin comonomers, in the presence of:...
US-9,938,358 Animal models and therapeutic molecules
The invention discloses methods for the generation of chimaeric human non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so...
US-9,938,357 Animal models and therapeutic molecules
The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so...
US-9,938,356 Binding molecules specific for CD73 and uses thereof
The present disclosure provides anti-CD73 binding molecules, e.g., antibodies and antigen binding fragments thereof. Also provided are pharmaceutical...
US-9,938,355 Antibodies to argininosuccinate synthase and related methods
Antibodies, and antigen-binding fragments, which specifically bind to argininosuccinate synthase, and related compositions, kits, and methods of use, which are...
US-9,938,354 Lin28-mediated control of let-7 biogenesis
The present embodiments provide for compositions and methods that regulate microRNA-binding protein-mediated miRNA biogenesis; for example Lin28-mediated...
US-9,938,353 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
Embodiments herein report compositions of alpha-1 antitrypsin fusion polypeptides or peptide derivatives thereof. In certain embodiments, compositions and...
US-9,938,352 Antigen binding proteins that bind ErbB3
There is disclosed compositions and methods relating to or derived from anti-ErbB3 antibodies. More specifically, there is disclosed fully human antibodies that...
US-9,938,351 Uses of monoclonal antibody 8H9
This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention...
US-9,938,350 Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods...
Compositions including an antibody single-chain variable fragment (scFv) conjugate that specifically binds to ROR1 tumor-associated antigen are provided. The...
US-9,938,349 Antibody which specifically binds to human CRTH2
There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which...
US-9,938,348 Stimulation via TLR4/MD-2 to reverse type 1 diabetes
Disclosed are methods and compositions for treating Type I diabetes in a subject. Agents selected from a TLR4 agonist, a TLR4/MD-2 agonist, or a combination...
US-9,938,347 Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereof
This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such...
US-9,938,346 Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
Provided are monospecific and bispecific antibodies that are useful as anti-neoplastic agents and that bind specifically to human IGF-1R and human ErbB3....
US-9,938,345 Human antibodies to PD-L1
The present invention provides antibodies that bind to the T-cell co-inhibitor ligand programmed death-ligand1 (PD-L1) protein, and methods of use. In various...
US-9,938,344 Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
This invention relates to humanized antibodies that selectively bind the 31.1 epitope on the A33 protein differentially expressed in cancers including, lung...
US-9,938,343 Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3...
For determining the presence and amount of human interleukin 3 (IL-3) in a sample, the present invention provides a diagnostic method, wherein an ...
US-9,938,342 Nucleic acid encoding anti-IL-17A antibodies
The present disclosure relates to antibodies and proteins comprising an antigen-binding portion thereof that specifically bind to the pro-inflammatory cytokine...
US-9,938,341 Antibodies that specifcally bind Sost and Wise peptides
The present invention is directed to isolated polypeptides and antibodies suitable for producing therapeutic preparations, methods, and kits relating to bone...
US-9,938,340 Amino acid sequence presenting fusion polypeptide and its use
Herein is reported a fusion polypeptide according to formula I NH.sub.2--S.sub.2--X.sub.1--S.sub.1--COOH (formula I) wherein X.sub.1 comprises either a random...
US-9,938,339 Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the...
US-9,938,338 Antibody possessing an affinity for epithelial secretory and nervous tissue, as well as tumour tissue derived...
We disclose the use of bacterial antigens and obtained antibodies. The resulting antibodies can be used in the diagnosis of tumors by immunohistochemistry and...
US-9,938,337 Reimmunization and antibody design
The present invention relates to methods for harvesting of antibodies from an antibody library. The antibodies are harvested by utilizing a certain epitope that...
US-9,938,336 Sequence based engineering and optimization of single chain antibodies
The invention provides methods of using sequence based analysis and rational strategies to modify and improve the structural and biophysical properties of...
US-9,938,335 Glucagon and GLP-1 co-agonist compounds
The present invention provides glucagon and GLP-1 co-agonist compounds that are useful in the treatment of type 2 diabetes, obesity, nonalcoholic fatty liver...
US-9,938,334 Insulin secreting polypeptides
This document provides methods and materials related to insulin secreting polypeptides. For example, polypeptides having the ability to induce insulin secretion...
US-9,938,333 Modified leptin polypeptides and their uses
Modified human leptin polypeptides and uses thereof are provided.
US-9,938,332 Modified ghrelin peptides
The present invention provides a peptide-type compound which induces secretion of growth hormone and which has the activity of increasing the intracellular...
US-9,938,331 Biologically active proteins having increased in vivo and/or in vitro stability
The present invention provides unstructured recombinant polymers (URPs) and proteins containing one or more of the URPs. The present invention also provides...
US-9,938,330 Nanoscale process to generate reagents selective for individual protein variants
The present invention provides devices and methods to separate and concentrate target protein species at a microliter scale and to generate reagents to those...
US-9,938,329 Peptides
The present invention provides a peptide at least partially derivable from human Thyroid Stimulating Hormone Receptor (TSHR) which peptide is capable of binding...
US-9,938,328 Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
A method for treating alopecia and/or hair depigmentation includes administering to a subject in need of such treatments a synthetic peptide, which has an amino...
US-9,938,327 Expression constructs and methods of genetically engineering methylotrophic yeast
Methods and materials for genetically engineering methylotrophic yeast are provided.
US-9,938,326 Pneumococcal vaccine containing pneumococcal surface protein A
A pneumococcal vaccine comprising a fusion protein at least comprising a full-length family 1 pneumococcal surface protein A (PspA) or a fragment thereof, and a...
US-9,938,325 HIV-1 antigens with discrete conformational forms in the V1/V2 domain and methods of use thereof
The present invention relates to a novel composition of HIV-1 Env proteins that contain structurally and immunologically distinct VI/V2 domains. Methods of...
US-9,938,323 Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase
The invention disclosed herein relates to cytotoxic cyclic peptides of Formula (I), methods of inhibiting RNA polymerase with such cyclic peptides,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.